While some authors reported that high HIF-1α expression may implicate poor prognosis [22] and shorter disease free survival, others found that HIF-2α overexpression rather than HIF-1α is a marker of poor prognosis in NSCLC [23]. The gene discussed is EPAS1; the disease is non-small cell lung carcinoma.